Show All
Where is the Company incorporated?
Where is Rallybio’s corporate headquarters?
234 Church Street, Suite 1020, New Haven, CT 06510
When was the Company founded?
Rallybio was founded in January 2018 with a mission to identify and accelerate the development of life-transforming therapies for patients with severe and rare diseases.
When did Rallybio become a public company?
Rallybio became a public company on July 29, 2021.
What is Rallybio’s fiscal year end?
December 31
On which exchange is Rallybio listed and what is the ticker symbol?
Rallybio’s stock is traded on The NASDAQ Global Market under the symbol “RLYB”.
Does Rallybio pay dividends?
Rallybio does not currently, nor do we expect to declare or pay any cash or other dividends on our common stock in the foreseeable future.
Whom should I contact regarding investor inquiries?
How can I receive Rallybio’s press releases, financial reports and other information?
To be added to Rallybio’s email distribution list, please visit the Investors website and sign up for email alerts.
How can I view documents Rallybio has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
You can visit the Financial Information page in the Investors section of our website. SEC filings can also be accessed from the SEC at
Who is Rallybio’s transfer agent and how do I contact them?

Computershare is our stock transfer agent. For questions regarding your shares, certificates, and other share-specific information, please contact Computershare in one of several ways:


Telephone Inquiries:
1-800-736-3001, option 1 (U.S.)
1-781-575-3100, option 1 (non-U.S.)

Email Inquiries:

Written Requests:

By Mail:
P.O. Box 505000
Louisville, KY 40233-5000

By Overnight Delivery:
462 South 4th Street, Suite 1600
Louisville, KY 40202



How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate?
Contact our transfer agent Computershare:
Does Rallybio have a direct stock purchase plan?
Rallybio does not currently offer a direct stock purchase plan.
For any additional investor questions not on this list, please contact